Name: Alamag Plus
- Alamag Plus brand name
- Alamag Plus missed dose
- Alamag Plus adult dose
- Alamag Plus 400 mg
- Alamag Plus drug
Alamag Plus Overview
What should I discuss with my healthcare provider before taking this medicine?
You should not use aluminum hydroxide, magnesium hydroxide, and simethicone if you are allergic to it.
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:
kidney disease; or
if you are on a low-magnesium diet.
It is not known whether aluminum hydroxide, magnesium hydroxide, and simethicone will harm an unborn baby. Ask a doctor before using this medicine if you are pregnant.
Ask a doctor before using this medicine if you are breast-feeding a baby.
Do not give this medicine to a child younger than 12 years old without medical advice.
What happens if I miss a dose?
Since this medicine is used when needed, you may not be on a dosing schedule. If you are on a schedule, use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Usual Adult Dose for Dyspepsia
Al hydroxide/Mg hydroxide/simethicone 400 mg-400 mg-40 mg to 1600 mg-1600 mg-160 mg four times daily.
The maximum daily dose Al hydroxide/Mg hydroxide/simethicone is 4800 mg-4800 mg-480 mg four times a day.
The most common adverse effect associated with aluminum antacids is constipation.
Magnesium containing antacids commonly cause a laxative effect.
Patients with renal failure may accumulate aluminum with chronic use. Serum aluminum levels should be monitored or another antacid chosen.
Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes.
Do not use drug before consulting with a doctor if you have kidney disease.
Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract, thus decreasing phosphate absorption which can lead to hypophosphatemia. In patients on hemodialysis who are maintained on aluminum antacids, serum phosphate concentrations should be monitored at monthly or bimonthly intervals.